nach oben

Erschienen in:

05.08.2017 | Original Article

GBV-C/HIV-1 coinfection is associated with low HIV-1 viral load and high CD4⁺ T lymphocyte count

verfasst von: Bárbara Katharine Barbosa de Miranda, Keyla Santos Guedes de Sá, Andrea Nazaré Rangel da Silva, Rosimar Neris Martins Feitosa, Izaura Maria Vieira Cayres-Vallinoto, Ricardo Ishak, Antonio Carlos Rosário Vallinoto

Erschienen in: Archives of Virology | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Abstract

GB virus C (GBV-C) is a lymphotropic virus with a low level or non-existent replication in the liver. The interaction between HIV-1 and GBV-C apparently reduces the progression of HIV-1 infection to AIDS and improves the quality of life of HIV-1 infected individuals. A cross-sectional study was established to determine the possible effect of HIV-1/GBV-C coinfection on HIV-1 viral load and CD4⁺ T lymphocyte counts. Samples from 313 HIV-1 infected persons from the Virus Laboratory of the Federal University of Pará as well as demographic and clinical information were obtained from medical records. This study used a nested PCR method to determine GBV-C viremia. The prevalence of HIV-1/GBV-C coinfection was 17%. There were no significant differences in the distribution according to age, sex or ethnicity between the groups. The differences in HIV-1 viral load and CD4⁺ T lymphocyte count between the HIV-1 and HIV-1/GBV-C groups were highly significant, indicating that coinfection results in lower viral loads and higher CD4⁺ T lymphocyte counts compared to HIV-1 mono-infection. The results indicate a protective effect among coinfected individuals.

Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG et al (1995) Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 92:3401–3405CrossRefPubMedPubMedCentral

Linnen J, Wages J, Zhang-Keck ZY, Fry KE, Krawczynski KZ, Alter H et al (1996) Molecular cloning and disease association of Hepatitis G virus: a transfusion-transmissible agent. Science 271:505–508CrossRefPubMed

Alter HJ (1996) The cloning and clinical implications of HGV and HGBV-C. N Engl J Med 334:1536–1537CrossRefPubMed

Tucker TJ, Smuts HE (2001) Review of the epidemiology, molecular characterization and tropism of the hepatitis G virus/GBV-C. Clin Lab 47:239–248PubMed

AbuOdeh RO, Al-Absi E, Ali NH, Khalili M, Al-Mawlawi N, Hadwan TA et al (2015) Detection and phylogenetic analysis of human pegivirus (GBV-C) among blood donors and patients infected with Hepatitis B virus (HBV) in Qatar. J Med Virol 87:2074–2081CrossRefPubMed

Odeh RA, Yasin S, Nasrallah G, Babi Y (2010) Rates of infection and phylogenetic analysis of GB virus-C among Kuwaiti and Jordanian blood donors. Intervirology 53:402–407CrossRefPubMed

Supapol WB, Remis RS, Raboud J, Millson M, Tappero J, Kaul R et al (2011) Prevalence and correlates of GB virus C infection in HIV-infected and HIV-uninfected pregnant women in Bangkok, Thailand. J Med Virol 83:33–44CrossRef

Liu Z, Li L, Chen Z, Xu M, Zhang T, Jiao Y et al (2012) Prevalence of GB virus type C viraemia in MSM with or without HIV-1 infection in Beijing, China. Epidemiol Infect 140:2199–2209CrossRefPubMed

Rodriguez AK, Garzaro DJ, Loureiro CL, Gutierrez CR, Ameli G, Jaspe RC et al (2014) HIV-1 and GBV-C co-infection in Venezuela. J Infect Dev Ctries 8:863–868CrossRefPubMed

10.

Alcalde R, Nishiya A, Casseb J, Inocencio L, Fonseca LA, Duarte AJ (2010) Prevalence and distribution of the GBV-C/HGV among HIV-1-infected patients under anti-retroviral therapy. Virus Res 151:148–152CrossRefPubMed

11.

Keys JR, Leone PA, Eron JJ, Alexander K, Brinson M, Swanstrom R (2014) Large scale screening of human sera for HCV RNA and GBV-C RNA. J Med Virol 86:473–477CrossRefPubMed

12.

Blackard JT, Ma G, Welge JA, King CC, Taylor LE, Mayer KH et al (2014) GB virus C (GBV-C) infection in Hepatitis C virus (HCV) seropositive women with or at risk for HIV infection. PLoS One 9:e114467CrossRefPubMedPubMedCentral

13.

Claret G, Noguera A, Gonzalez-Cuevas A, Garcia-Garcia JJ, Fortuny C, Munoz-Almagro C (2008) The prevalence of GB virus C/Hepatitis G virus RNA among healthy and HCV-infected Catalan children. Eur J Pediatr 167:991–994CrossRefPubMed

14.

Tenckhoff S, Kaiser T, Bredeek F, Donfield S, Menius E, Lail A et al (2012) Role of GB virus C in human immunodeficiency virus type-1- and Hepatitis C virus-infected hemophiliac children and adolescents. J Acquir Immune Defic Syndr 61:243–248CrossRefPubMed

15.

Muerhoff AS, Dawson GJ, Desai SM (2006) A previously unrecognized sixth genotype of GB virus C revealed by analysis of 5′-untranslated region sequences. J Med Virol 78:105–111CrossRefPubMed

16.

Smith DB, Cuceanu N, Davidson F, Jarvis LM, Mokili JL, Hamid S et al (1997) Discrimination of Hepatitis G virus/GBV-C geographical variants by analysis of the 5′ non-coding region. J Gen Virol 78:1533–1542CrossRefPubMed

17.

Muerhoff AS, Leary TP, Sathar MA, Dawson GJ, Desai SM (2005) African origin of GB virus C determined by phylogenetic analysis of a complete genotype 5 genome from South Africa. J Gen Virol 86:1729–1735CrossRefPubMed

18.

Souza IE, Zhang W, Diaz RS, Chaloner K, Klinzman D, Stapleton JT (2006) Effect of GB virus C on response to antiretroviral therapy in HIV-infected Brazilians. HIV Med 7:25–31CrossRefPubMed

19.

Tillmann HL, Heiken H, Knapik-Botor A, Heringlake S, Ockenga J, Wilber JC et al (2001) Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 345:715–724CrossRefPubMed

20.

Williams CF, Klinzman D, Yamashita TE, Xiang J, Polgreen PM, Rinaldo C et al (2004) Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 350:981–990CrossRefPubMed

21.

Zhang W, Chaloner K, Tillmann HL, Williams CF, Stapleton JT (2006) Effect of early and late GB virus C viraemia on survival of HIV-infected individuals: a meta-analysis. HIV Med 7:173–180CrossRefPubMed

22.

Hattori J, Okumura N, Yamazaki Y, Uchiyama M, Hamaguchi M, Nishiyama Y et al (2007) Beneficial effect of GB virus C co-infection in Human Immunodeficiency Virus type 1-infected individuals. Microbiol Immunol 51:193–200CrossRefPubMed

23.

Lefrère JJ, Ferec C, Roudot-Thoraval F, Loiseau P, Cantaloube J, Biagini P et al (1999) GBV-C/Hepatitis G virus (HGV) RNA load in immunodeficient individuals and in immunocompetent individuals. J Med Virol 59:32–37CrossRefPubMed

24.

Xiang J, Wunschmann S, Diekema DJ, Klinzman D, Patrick KD, George SL et al (2001) Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 345:707–714CrossRefPubMed

25.

Yeo AE, Matsumoto A, Hisada M, Shih JW, Alter HJ, Goedert JJ (2000) Effect of Hepatitis G virus infection on progression of HIV infection in patients with hemophilia. Multicenter Hemophilia Cohort Study. Ann Intern Med 132:959–963CrossRefPubMed

26.

Xiang J, George SL, Wunschmann S, Chang Q, Klinzman D, Stapleton JT (2004) Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet 363:2040–2046CrossRefPubMed

27.

Jung S, Knauer O, Donhauser N, Eichenmuller M, Helm M, Fleckenstein B et al (2005) Inhibition of HIV strains by GB virus C in cell culture can be mediated by CD4 and CD8 T-lymphocyte derived soluble factors. AIDS 19:1267–1272CrossRefPubMed

28.

Nunnari G, Nigro L, Palermo F, Attanasio M, Berger A, Doerr HW et al (2003) Slower progression of HIV-1 infection in persons with GB virus C co-infection correlates with an intact T-helper 1 cytokine profile. Ann Intern Med 139:26–30CrossRefPubMed

29.

Siegal F (2003) Interferon-producing plasmacytoid dendritic cells and the pathogenesis of AIDS. Res Initiat Treat Action 8:10–13PubMed

30.

Capobianchi M, Lalle E, Martini F, Poccia F, D’Offizi G, Antonucci G et al (2006) Influence of GBV-C infection on the endogenous activation of the IFN system in HIV-1 co-infected patients. Cell Mol Biol 52:3–8PubMed

31.

Brasil. Ministério da Saúde (2015) Departamento de Vigilância, Prevenção e Controle das IST, do HIV/Aids e das Hepatites Virais, 2015. Protocolo Clínico e Diretrizes Terapêuticas para Manejo da Infecção pelo HIV em Adultos. http://www.aids.gov.br/sites/default/files/anexos/publicacao/2013/55308/protocolofinal_31_7_2015_pdf_31327.pdf. Accessed 26 Jun 2017

32.

Ayres M, Ayres M, Ayres D, Santos A (2007) BioEstat 5.0: aplicações estatísticas nas áreas das ciências biológicas e médicas. Instituto de Desenvolvimento Sustentável Mamirauá - IDSM/MCT/CNPq, vol 1. p 364

33.

Rey D, Vidinic-Moularde J, Meyer P, Schmitt C, Fritsch S, Lang JM et al (2000) High prevalence of GB virus C/Hepatitis G virus RNA and antibodies in patients infected with human immunodeficiency virus type 1. Eur J Clin Microbiol Infect Dis 19:721–724CrossRefPubMed

34.

Rendina D, Vigorita E, Bonavolta R, D’Onofrio M, Iura A, Pietronigro MT et al (2001) HCV and GBV-c/HGV infection in HIV positive patients in southern Italy. Eur J Epidemiol 17:801–807CrossRefPubMed

35.

Gutierrez RA, Dawson GJ, Knigge MF, Melvin SL, Heynen CA, Kyrk CR et al (1997) Seroprevalence of GB virus C and persistence of RNA and antibody. J Med Virol 53:167–173CrossRefPubMed

36.

Ribeiro-dos-Santos G, Nishiya A, Nascimento C, Bassit L, Chamone D, Focaccia R et al (2002) Prevalence of GB virus C (Hepatitis G virus) and risk factors for infection in Sao Paulo, Brazil. Eur J Clin Microbiol Infect Dis 21:438–443CrossRefPubMed

37.

Levi JE, Contri DG, Lima LP, Takaoka DT, Garrini RH, Santos W et al (2003) High prevalence of GB virus C/Hepatitis G virus RNA among Brazilian blood donors. Rev Inst Med Trop Sao Paulo 45:75–78CrossRefPubMed

38.

Amarante MK, Miranda HC, de Oliveira CEC, de Oliveira KB, Watanabe MAE (2004) Detecção do RNA HGV/GBV-C em indivíduos saudáveis não portadores de HBV, HIV-1/2 e HCV. Semina: Ciências Biológicas e da Saúde 25:39–44

39.

Ramezani A, Mohraz M, Vahabpour R, Jam S, Banifazl M, Eslamifar A et al (2008) Frequency of Hepatitis G virus infection among HIV positive subjects with parenteral and sexual exposure. J Gastrointestin Liver Dis 17:269–272PubMed

40.

Scallan MF, Clutterbuck D, Jarvis LM, Scott GR, Simmonds P (1998) Sexual transmission of GB virus C/hepatitis G virus. J Med Virol 55:203–208CrossRefPubMed

41.

Jarvis L, Davidson F, Hanley J, Yap P, Ludlam C, Simmonds P (1996) Infection with Hepatitis G virus among recipients of plasma products. Lancet 348:1352–1355CrossRefPubMed

42.

Hekmat S, Mohraz M, Vahabpour R, Jam S, Bahramali G, Banifazl M et al (2008) Frequency and genotype of GB virus C among Iranian patients infected with HIV. J Med Virol 80:1941–1946CrossRefPubMed

43.

Brasil. Ministério da Saúde, Secretaria de Vigilância em Saúde (2015) Programa nacional de DST e AIDS. Boletim epidemiológico—AIDS

44.

Toyoda H, Fukuda Y, Hayakawa T, Takamatsu J, Saito H (1998) Effect of GB virus C/Hepatitis G virus coinfection on the course of HIV infection in hemophilia patients in Japan. J Acquir Immune Defic Syndr Hum Retrovirol 17:209–213CrossRefPubMed

45.

Lefrère JJ, Roudot-Thoraval F, Morand-Joubert L, Petit JC, Lerable J, Thauvin M et al (1999) Carriage of GB virus C/Hepatitis G virus RNA is associated with a slower immunologic, virologic, and clinical progression of human immunodeficiency virus disease in coinfected persons. J Infect Dis 179:783–789CrossRefPubMed

46.

Martinez-Picado J, Deeks SG (2016) Persistent HIV-1 replication during antiretroviral therapy. Curr Opin HIV AIDS 11:417–423CrossRefPubMedPubMedCentral

47.

Koedel Y, Eissmann K, Wend H, Fleckenstein B, Reil H (2011) Peptides derived from a distinct region of GB Virus C glycoprotein E2 mediate strain specific HIV-1 entry inhibition. J Virol 85:7037–7047CrossRefPubMedPubMedCentral

48.

George SL, Varmaz D, Tavis JE, Chowdhury A (2012) The GB virus C (GBV-C) NS3 serine protease inhibits HIV-1 replication in a CD4⁺ T lymphocyte cell line without decreasing HIV receptor expression. PLoS One 7:e30653CrossRefPubMedPubMedCentral

49.

Tillmann HL, Manns MP, Claes C, Heiken H, Schmidt RE, Stoll M (2004) GB virus C infection and quality of life in HIV-positive patients. AIDS Care 16:736–743CrossRefPubMed

50.

Ruiz V, Espínola L, Mathet VL, Perandones CE, Oubiña JR (2006) Design, development and evaluation of a competitive RT-PCR for quantitation of GBV-C RNA. J Virol Methods 136:58–64CrossRefPubMed

51.

Mosam A, Sathar MA, Dawood H, Cassol E, Esterhuizen TM, Coovadia HM (2007) Effect of GB virus C co-infection on response to generic HAART in African patients with HIV-1 clade C infection. AIDS 21:1377–1379CrossRefPubMed

52.

Li C, Collini P, Danso K, Owusu-Ofori S, Dompreh A, Candotti D, Opare-Sem O, Allain JP (2006) Gb virus C And Hiv-1 Rna load in single virus and co-infected west african individuals. Aids 20:379–386CrossRefPubMed

Titel: GBV-C/HIV-1 coinfection is associated with low HIV-1 viral load and high CD4+ T lymphocyte count
verfasst von: Bárbara Katharine Barbosa de Miranda
Keyla Santos Guedes de Sá
Andrea Nazaré Rangel da Silva
Rosimar Neris Martins Feitosa
Izaura Maria Vieira Cayres-Vallinoto
Ricardo Ishak
Antonio Carlos Rosário Vallinoto
Publikationsdatum: 05.08.2017
Verlag: Springer Vienna
Erschienen in: Archives of Virology / Ausgabe 11/2017
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-017-3514-y

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

GBV-C/HIV-1 coinfection is associated with low HIV-1 viral load and high CD4⁺ T lymphocyte count

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2017

Crystal structures of two forms of the Acanthamoeba polyphaga mimivirus Rab GTPase

Complete genome sequence of a new bipartite begomovirus infecting Macroptilium lathyroides in Brazil

SOCS1 and pattern recognition receptors: TLR9 and RIG-I; novel haplotype associations in Egyptian fibrotic/cirrhotic patients with HCV genotype 4

Detection of waterborne norovirus genogroup I strains using an improved real time RT-PCR assay

Immunological aspects of rabies: a literature review

Infectivity of Deinbollia mosaic virus, a novel weed-infecting begomovirus in East Africa

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin